MX2018002759A - Forma cristalina del inhibidor del receptor androgenico y metodo de preparacion de la misma. - Google Patents
Forma cristalina del inhibidor del receptor androgenico y metodo de preparacion de la misma.Info
- Publication number
- MX2018002759A MX2018002759A MX2018002759A MX2018002759A MX2018002759A MX 2018002759 A MX2018002759 A MX 2018002759A MX 2018002759 A MX2018002759 A MX 2018002759A MX 2018002759 A MX2018002759 A MX 2018002759A MX 2018002759 A MX2018002759 A MX 2018002759A
- Authority
- MX
- Mexico
- Prior art keywords
- crystal
- preparation
- compound
- formula
- androgen receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan una forma cristalina de un inhibidor del receptor androgénico, y un método de preparación de la misma. En términos particulares, se proporcionan un cristal tipo I de (S)-4-(3-(4-(2,3-dihidroxipropoxi)fenil)-4,4-dimetil-5-carbonil-2 -tioimidazolin-1-il)-2-(trifluorometil)benzonitrilo (un compuesto de la fórmula (I)) y un método de preparación del mismo, en donde el método comprende: 1) se agrega cualquier forma cristalina o forma amorfa del compuesto como se muestra por la fórmula (I), a una cantidad adecuada de un solvente orgánico, se calienta y se disuelve hasta que esté transparente, seguido por enfriamiento y cristalización, en donde el solvente orgánico se selecciona a partir de cualquiera de ésteres, cetonas, nitrilos y éteres que tienen 5 o menos átomos de carbono, o un solvente mixto del mismo; y 2) el cristal se filtra, lava y seca. El cristal tipo I obtenido del compuesto de la fórmula (I) tiene una buena estabilidad química y estabilidad de su forma cristalina, y el solvente de cristalización utilizado tiene una baja toxicidad y poca formación de residuos, y se puede utilizar mejor en tratamientos clínicos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510574141 | 2015-09-10 | ||
| CN201610073458 | 2016-02-02 | ||
| PCT/CN2016/096381 WO2017041622A1 (zh) | 2015-09-10 | 2016-08-23 | 一种雄性激素受体抑制剂的结晶形式及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018002759A true MX2018002759A (es) | 2018-08-01 |
Family
ID=58240573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002759A MX2018002759A (es) | 2015-09-10 | 2016-08-23 | Forma cristalina del inhibidor del receptor androgenico y metodo de preparacion de la misma. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10150739B2 (es) |
| EP (1) | EP3348546B1 (es) |
| JP (1) | JP6843116B2 (es) |
| KR (1) | KR20180048939A (es) |
| CN (1) | CN107001284B (es) |
| AU (1) | AU2016318700B2 (es) |
| BR (1) | BR112018003258A2 (es) |
| CA (1) | CA2996674A1 (es) |
| CY (1) | CY1123027T1 (es) |
| DK (1) | DK3348546T3 (es) |
| ES (1) | ES2794568T3 (es) |
| HR (1) | HRP20200852T1 (es) |
| HU (1) | HUE050459T2 (es) |
| LT (1) | LT3348546T (es) |
| MX (1) | MX2018002759A (es) |
| PL (1) | PL3348546T3 (es) |
| PT (1) | PT3348546T (es) |
| RS (1) | RS60448B1 (es) |
| RU (1) | RU2018109121A (es) |
| SI (1) | SI3348546T1 (es) |
| TW (1) | TWI708764B (es) |
| WO (1) | WO2017041622A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3348546T (lt) | 2015-09-10 | 2020-07-27 | Jiangsu Hengrui Medicine Co., Ltd. | Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdas |
| CN112300076B (zh) * | 2017-12-13 | 2022-10-25 | 江苏恒瑞医药股份有限公司 | 一种雄性激素受体抑制剂的晶型及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2579886A1 (en) * | 2004-09-09 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | Novel imidazolidine derivative and use thereof |
| MX346924B (es) * | 2005-05-13 | 2017-04-05 | Univ California | Compuestos de diarilhidantoina. |
| EP2416657A4 (en) * | 2009-04-09 | 2012-09-05 | Medivation Prostate Therapeutics Inc | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF |
| SI2894151T1 (sl) * | 2012-09-04 | 2021-01-29 | Shanghai Hengrui Pharmaceutical Co. Ltd. | Imidazolinski derivati, postopki za njihovo pripravo in njihove uporabe v medicini |
| JP2015534550A (ja) * | 2012-09-11 | 2015-12-03 | ドクター レディズ ラボラトリーズ リミテッド | エンザルタミドの多形形態およびその調製 |
| CN104356068A (zh) * | 2014-10-30 | 2015-02-18 | 杭州新博思生物医药有限公司 | 恩杂鲁胺新晶型及其制备方法 |
| LT3348546T (lt) | 2015-09-10 | 2020-07-27 | Jiangsu Hengrui Medicine Co., Ltd. | Androgeno receptorių inhibitoriaus kristalinė forma ir jos gavimo būdas |
-
2016
- 2016-08-23 LT LTEP16843560.0T patent/LT3348546T/lt unknown
- 2016-08-23 DK DK16843560.0T patent/DK3348546T3/da active
- 2016-08-23 PL PL16843560T patent/PL3348546T3/pl unknown
- 2016-08-23 SI SI201630801T patent/SI3348546T1/sl unknown
- 2016-08-23 AU AU2016318700A patent/AU2016318700B2/en not_active Ceased
- 2016-08-23 WO PCT/CN2016/096381 patent/WO2017041622A1/zh active Application Filing
- 2016-08-23 KR KR1020187009184A patent/KR20180048939A/ko not_active Application Discontinuation
- 2016-08-23 US US15/757,652 patent/US10150739B2/en active Active
- 2016-08-23 CA CA2996674A patent/CA2996674A1/en active Pending
- 2016-08-23 JP JP2018508712A patent/JP6843116B2/ja active Active
- 2016-08-23 PT PT168435600T patent/PT3348546T/pt unknown
- 2016-08-23 RU RU2018109121A patent/RU2018109121A/ru unknown
- 2016-08-23 MX MX2018002759A patent/MX2018002759A/es unknown
- 2016-08-23 CN CN201680003850.4A patent/CN107001284B/zh active Active
- 2016-08-23 ES ES16843560T patent/ES2794568T3/es active Active
- 2016-08-23 RS RS20200617A patent/RS60448B1/sr unknown
- 2016-08-23 HU HUE16843560A patent/HUE050459T2/hu unknown
- 2016-08-23 EP EP16843560.0A patent/EP3348546B1/en active Active
- 2016-08-23 BR BR112018003258-1A patent/BR112018003258A2/pt not_active Application Discontinuation
- 2016-09-07 TW TW105128891A patent/TWI708764B/zh active
-
2020
- 2020-05-26 HR HRP20200852TT patent/HRP20200852T1/hr unknown
- 2020-06-09 CY CY20201100522T patent/CY1123027T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3348546T3 (da) | 2020-07-06 |
| AU2016318700B2 (en) | 2020-05-07 |
| BR112018003258A2 (pt) | 2018-09-25 |
| CY1123027T1 (el) | 2021-10-29 |
| JP6843116B2 (ja) | 2021-03-17 |
| US10150739B2 (en) | 2018-12-11 |
| SI3348546T1 (sl) | 2020-09-30 |
| HRP20200852T1 (hr) | 2020-08-21 |
| CN107001284A (zh) | 2017-08-01 |
| LT3348546T (lt) | 2020-07-27 |
| CN107001284B (zh) | 2019-11-22 |
| EP3348546A1 (en) | 2018-07-18 |
| EP3348546A4 (en) | 2019-03-27 |
| RU2018109121A (ru) | 2019-10-10 |
| TWI708764B (zh) | 2020-11-01 |
| JP2018526364A (ja) | 2018-09-13 |
| RU2018109121A3 (es) | 2019-12-04 |
| US20180244628A1 (en) | 2018-08-30 |
| RS60448B1 (sr) | 2020-07-31 |
| ES2794568T3 (es) | 2020-11-18 |
| TW201713628A (zh) | 2017-04-16 |
| AU2016318700A1 (en) | 2018-04-05 |
| HUE050459T2 (hu) | 2020-12-28 |
| CA2996674A1 (en) | 2017-03-16 |
| WO2017041622A1 (zh) | 2017-03-16 |
| PT3348546T (pt) | 2020-05-29 |
| KR20180048939A (ko) | 2018-05-10 |
| PL3348546T3 (pl) | 2020-09-21 |
| EP3348546B1 (en) | 2020-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210507T1 (hr) | Supstituirani 5-fluoro-1h-pirazolopiridini u kristalnom obliku | |
| RU2016144197A (ru) | Фунгицидные производные n'-[2-метил-6[2-алкоксиэтокси]-3-пиридил]-n-алкилформамидина для применения в сельском хозяйстве | |
| EA201591429A1 (ru) | 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена | |
| MX2018008131A (es) | Forma cristalina del inhibidor de la btk quinasa y metodo de preparacion de la misma. | |
| MX2015010837A (es) | Compuestos de antranilamida, sus mezclas y el uso de los mismos como pesticidas. | |
| EA201291236A1 (ru) | Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10 | |
| WO2009025983A4 (en) | Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives | |
| MX353957B (es) | Carboxamidas heterociclicas fungicidas. | |
| WO2012003405A4 (en) | Sgc stimulators | |
| JP2013531029A5 (es) | ||
| MX2022008434A (es) | Herbicidas de piridazinona. | |
| PH12016501829A1 (en) | Plant disease control composition and method for controlling plant disease by application of same | |
| MX2021014531A (es) | Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos. | |
| CL2018000241A1 (es) | Método para preparar derivados de ácido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il) propanoico sustituido. | |
| PE20181144A1 (es) | Derivados de heteroarilo como inhibidores de parp | |
| NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
| TW201613931A (en) | Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof | |
| NZ738836A (en) | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid | |
| HRP20191431T1 (hr) | Postupak za pripravu (4s)-4-(4-cijano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1-6- naftiridin-3-karboksamida i njegovo pročišćavanje za uporabu kao aktivni farmaceutski pripravak | |
| MX2016008536A (es) | Derivados de fluoro-naftilo. | |
| MX2015014406A (es) | Carboxamidas fungicidas. | |
| JP2016518317A5 (es) | ||
| JP2016529319A5 (es) | ||
| CY1122468T1 (el) | Κρυσταλλικη μορφη διθειικου αναστολεα κινασης jak και μια μεθοδος παρασκευης αυτου | |
| CY1123027T1 (el) | Κρυσταλλικη μορφη αναστολεα υποδοχεα ανδρογονων και μεθοδος παρασκευης αυτου |